PL400808A1 - Process for obtaining of 4'-hydroxy-5,6-benzoflavone - Google Patents

Process for obtaining of 4'-hydroxy-5,6-benzoflavone

Info

Publication number
PL400808A1
PL400808A1 PL400808A PL40080812A PL400808A1 PL 400808 A1 PL400808 A1 PL 400808A1 PL 400808 A PL400808 A PL 400808A PL 40080812 A PL40080812 A PL 40080812A PL 400808 A1 PL400808 A1 PL 400808A1
Authority
PL
Poland
Prior art keywords
benzoflavone
hydroxy
obtaining
formula
fact
Prior art date
Application number
PL400808A
Other languages
Polish (pl)
Other versions
PL218584B1 (en
Inventor
Jaroslaw Tomasz Poplonski
Ewa Huszcza
Tomasz Tronina
Anna Madej
Original Assignee
Uniwersytet Przyrodniczy We Wroclawiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy We Wroclawiu filed Critical Uniwersytet Przyrodniczy We Wroclawiu
Priority to PL400808A priority Critical patent/PL218584B1/en
Publication of PL400808A1 publication Critical patent/PL400808A1/en
Publication of PL218584B1 publication Critical patent/PL218584B1/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Sposób wytwarzania 4'-hydroksy-5,6-benzoflawonu o wzorze 2, polega na tym, ze substrat, którym jest 5,6-benzoflawon o wzorze 1, poddaje sie mikrobiologicznej transformacji, przy uzyciu systemu enzymatycznego grzybów z gatunku Aspergillus glaucus. Zwiazek ten jest biologicznie czynny i moze miec zastosowanie w przemysle farmaceutycznym.The method of producing 4'-hydroxy-5,6-benzoflavone of the formula 2 consists in the fact that the substrate, which is 5,6-benzoflavone of the formula 1, is subjected to microbial transformation using the enzyme system of the fungus Aspergillus glaucus. This compound is biologically active and can be used in the pharmaceutical industry.

PL400808A 2012-09-17 2012-09-17 Process for obtaining of 4'-hydroxy-5,6-benzoflavone PL218584B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL400808A PL218584B1 (en) 2012-09-17 2012-09-17 Process for obtaining of 4'-hydroxy-5,6-benzoflavone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL400808A PL218584B1 (en) 2012-09-17 2012-09-17 Process for obtaining of 4'-hydroxy-5,6-benzoflavone

Publications (2)

Publication Number Publication Date
PL400808A1 true PL400808A1 (en) 2013-04-15
PL218584B1 PL218584B1 (en) 2015-01-30

Family

ID=48536504

Family Applications (1)

Application Number Title Priority Date Filing Date
PL400808A PL218584B1 (en) 2012-09-17 2012-09-17 Process for obtaining of 4'-hydroxy-5,6-benzoflavone

Country Status (1)

Country Link
PL (1) PL218584B1 (en)

Also Published As

Publication number Publication date
PL218584B1 (en) 2015-01-30

Similar Documents

Publication Publication Date Title
MY197720A (en) Bicyclic heterocycles as fgfr inhibitors
WO2013184755A3 (en) Seca inhibitors and methods of making and using thereof
BR112015019997A2 (en) METHODS OF SACHARIFYING AND FERMENTATING A CELLULOSIC MATERIAL
CR20110620A (en) DERIVATIVES OF N- (HETERO) ARIL-PIRROLIDINA DE PIRAZO-4-IL-PIRROLO [2,3-D] PIRIMIDINES AND PIRROL-3-IL-PIRROLO [2,3-D] PYRIMIDINES AS IHNIBITORS OF THE JANUS KINASE
BR112012015721A2 (en) covalent ligand-driven protein modification
WO2013029013A8 (en) Enzyme producing bacillus strains
BR112015018783A2 (en) dry intimate mixture, composition, method of preparing a dry intimate mixture and method of increasing germination, growth, metabolism and / or enzymatic activity of bacterial spores
MY159156A (en) Antibody formulation
EA033311B1 (en) Benzoxaborole derivatives as antibacterial agents
NZ597075A (en) 1, 2, 4-thiazolidin-3-one derivatives as AMP-activated protein kinase (AMPK) agonists for treating cancer
AU2017285758A1 (en) Method for improving salt tolerance of plant
PH12016500667A1 (en) Array of age-tailored infant formula with optimum protein content and lactose content
CL2009002129A1 (en) Carboxyamide derivatives of lantibiotics; preparation process of said lantibiotics; pharmaceutical composition containing it; Useful in the treatment of bacterial infections.
UA113962C2 (en) PHARMACEUTICAL COMPOSITION CONTAINING APOMORPHINE AS AN ACTIVE INGREDIENT
SG10201804952QA (en) Glucosylceramide synthase inhibitors
PL407699A1 (en) Method of obtaining 7-O-�-D-glucopyranosyl-5-hydroxy-4'-methoxyisoflavone and 5-O-�-D-glucopyranosyl-7-hydroxy-4'-methoxyisoflavone
BR112016009619A2 (en) methods for saccharifying a cellulosic material and for producing a fermentation product from cellulosic material
MX2010010017A (en) Linear and cyclic guanidine derivatives, method of preparation and uses thereof.
PL400808A1 (en) Process for obtaining of 4'-hydroxy-5,6-benzoflavone
GEP201706614B (en) Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process
PL400806A1 (en) Process for obtaining of 4'-hydroxy-7,8-benzoflavone
PL418556A1 (en) 7-O-β-D-4'''-O-methyl-glucopyranosyl-5.4'-dihydroxyflavanone and method for obtaining 7-O-β-D-4'''-O-methyl-glucopyranosyl-5.4'-dihydroxyflavanone
BR112018005268A2 (en) A Highly Stable Non-Vesicular Nanoparticles and Its Application in the Treatment of Microbial Infection
PL400807A1 (en) Process for the preparation of 4'-hydroxy-5,6-benzoflavone
PL400805A1 (en) Process for the preparation of 4'-hydroxy-7,8-benzoflavone

Legal Events

Date Code Title Description
LICE Declarations of willingness to grant licence

Effective date: 20140710